Skip to content

Effect of Prophylactic Application of 40Hz Transcranial Stimulation in AICU on Incidence of Postoperative Delirium in Elderly Patients Undergoing Elective Gastrointestinal Surgery

Effect of Prophylactic Application of 40Hz Transcranial Stimulation in AICU on Incidence of Postoperative Delirium in Elderly Patients Undergoing Elective Gastrointestinal Surgery

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06542978
Enrollment
98
Registered
2024-08-07
Start date
2024-05-01
Completion date
2025-03-01
Last updated
2024-10-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anesthesia, Elderly, Postoperative Delirium

Brief summary

Postoperative delirium is an acute central nervous system dysfunction caused by surgical stress, which is manifested by postoperative acute, non-specific changes in consciousness level, attention, cognitive ability and disturbance of sleep and wake cycles. It is one of the most common surgical complications in the elderly, occurring in more than 75% of patients receiving mechanical ventilation in the intensive care unit(ICU).Exogenous 40 Hz stimulation can improve cognitive functioning.Therefore, the aim of this study was to investigate the effect of exogenous 40Hz stimulation on the incidence of postoperative delirium in elderly patients undergoing elective gastrointestinal surgery in AICU.

Interventions

Exogenous 40HZ stimulation is a physical intervention that can drive oscillations in the gamma range, and the oscillations and pulses caused at the corresponding frequency can lead to a significant reduction in β-amyloid, reverse tau hyperphosphorylation, and thereby improve the cognitive function of patients.

Sponsors

Henan Provincial People's Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
65 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* 1.Age ≥ 65 years old,gender not limited * 2.ASA classification Ⅱ \ Ⅳ * 3.Elective gastrointestinal general anesthesia surgery

Exclusion criteria

* 1.History of schizophrenia, epilepsy, Parkinson's disease, or myasthenia gravis * 2.Pre-operative coma, severe dementia, speech impairment or severe illness incapacitated and unable to communicate * 3.Delirium on admission or pre-operative delirium, brain injury * 4.Severely infected person * 5.Severe liver dysfunction (Child-Pugh C), severe renal insufficiency (preoperative dialysis) * 6.Severe hearing or vision impairment

Design outcomes

Primary

MeasureTime frameDescription
The incidence of postoperative deliriumDay 1, Day 2, Day 3 ,Day 4, Day 5, Day 6,Day 7 after surgeryPostoperative delirium was assessed using the CAM-ICU scale.The RASS score (The Richmond Agitation-Sedation Scale) was used to assess arousal. When the patient's RASS score is not -4 /-5, delirium evaluation can continue considering the patient's wakefulness status.CAM-ICU scale contains four features (Feature 1, Feature 2, Feature 3, and Feature 4). Delirium can be diagnosed when the patient is positive for features 1, 2, 3, or 4.

Secondary

MeasureTime frameDescription
Blood Markershalf hour, 6hours, 24hours and 48hours after transfer to aicuSerum Tau proteomic analysis and CRP, IL-6, and TNF-ɑ were recorded
Sleep quality8:00 to 10:00 every morning for the first three days after surgeryThe Chinese version of the Richards-Campbell Sleep Quality Scale Score (RCSQ) was used to evaluate sleep quality. RCSQ scoring average for five projects, including 0 \ 25 points on behalf of the poor quality of sleep, on behalf of the sleep quality of 76 \ 100 points; The higher the score says sleep quality, the better
The incidence of pain6hours, 24hours, 48hours after surgeryMark a 0-10cm horizontal line on the paper with a ruler, and determine the score in millimeters (mm). The score range is 0-100mm, and the higher the score, the greater the pain intensity; No pain (0-4 mm), mild pain (5-44 mm), moderate pain (45-74 mm), severe pain (75-100 mm).

Countries

China

Contacts

Primary ContactZhang jiaqiang
hnmzxh@163.com037165580728

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026